Status:

COMPLETED

Study Evaluating the Safety and Efficacy of AR-15512

Lead Sponsor:

Aerie Pharmaceuticals

Conditions:

Dry Eye Disease

Eligibility:

All Genders

30+ years

Phase:

PHASE3

Brief Summary

This will be a Phase 3, multicenter, vehicle-controlled, double-masked, randomized study conducted at approximately 20 sites in the United States. All subjects enrolled will have dry eye disease (DED)...

Detailed Description

At the end of the Screening Visit, all qualified subjects will be assigned to administer one drop of AR-15512 Vehicle twice a day to both eyes for approximately 14 days (vehicle run-in period). After ...

Eligibility Criteria

Inclusion

  • Key
  • Signs and symptoms of dry eye disease (DED) at the Screening and Baseline visits;
  • Corrected visual acuity of +0.70 logarithm Minimum angle of resolution (LogMAR) or better in both eyes at Screening and Baseline visits;
  • Other protocol-specified inclusion criteria may apply.
  • Key

Exclusion

  • History or presence of any ocular disorder or condition (other than DED) in either eye that would, in the opinion of the investigator, likely interfere with the interpretation of the study results or subject safety;
  • Regular use of lid hygiene within 14 days prior to the Screening visit or any planned use during the study;
  • Use of artificial tears within 2 hours prior to the Screening visit or anticipated use during the study;
  • Medication use as specified in the protocol;
  • History or presence of significant systemic disease;
  • Other protocol-specified exclusion criteria may apply.

Key Trial Info

Start Date :

May 9 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

July 24 2023

Estimated Enrollment :

465 Patients enrolled

Trial Details

Trial ID

NCT05285644

Start Date

May 9 2022

End Date

July 24 2023

Last Update

July 23 2025

Active Locations (23)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (23 locations)

1

Global Research Management, Inc

Glendale, California, United States, 90027

2

Premiere Practice Management, LLC

Torrance, California, United States, 90505

3

Vision Institute

Colorado Springs, Colorado, United States, 80907

4

The Eye Care Group

Waterbury, Connecticut, United States, 06708

Study Evaluating the Safety and Efficacy of AR-15512 | DecenTrialz